Neoadjuvant patient decision aid
For many women recently diagnosed with breast cancer, the treatment process can be overwhelming and stressful. In certain situations, doctors may offer treatment with chemotherapy, targeted therapy or hormonal therapy before surgery to the breast and lymph nodes (neoadjuvant).
The Neoadjuvant Patient Decision Aid has been created by researchers at Breast Cancer Trials to help these women make an informed decision about their treatment. It is recommended for women who have recently been diagnosed with early-stage breast cancer.
The Neoadjuvant Patient Decision Aid was developed by a team of experts led by Australian Breast Cancer Trials Medical Advisor, researcher and medical oncologist, Dr Nick Zdenkowski.
15 May 2022